These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 33330900)
21. Gut Microbiota and Multiple Organ Dysfunction Syndrome (MODS). Chen P; Billiar T Adv Exp Med Biol; 2020; 1238():195-202. PubMed ID: 32323186 [TBL] [Abstract][Full Text] [Related]
22. Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota. Liu Y; Xu L; Yang Z; Wang D; Li T; Yang F; Li Z; Bai X; Wang Y Biomed Pharmacother; 2023 Jul; 163():114837. PubMed ID: 37156115 [TBL] [Abstract][Full Text] [Related]
23. [Role of the gut microbiome in the development and transfer of antibiotic resistances]. Appel TM; Vehreschild MJ Inn Med (Heidelb); 2022 Oct; 63(10):1043-1050. PubMed ID: 36048186 [TBL] [Abstract][Full Text] [Related]
24. Not Just Antibiotics: Is Cancer Chemotherapy Driving Antimicrobial Resistance? Papanicolas LE; Gordon DL; Wesselingh SL; Rogers GB Trends Microbiol; 2018 May; 26(5):393-400. PubMed ID: 29146383 [TBL] [Abstract][Full Text] [Related]
25. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli. Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114 [TBL] [Abstract][Full Text] [Related]
26. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants. Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279 [TBL] [Abstract][Full Text] [Related]
27. Antibiotics as both friends and foes of the human gut microbiome: The microbial community approach. Nogueira T; David PHC; Pothier J Drug Dev Res; 2019 Feb; 80(1):86-97. PubMed ID: 30370682 [TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship. Tan GSE; Tay HL; Tan SH; Lee TH; Ng TM; Lye DC Adv Ther; 2020 Oct; 37(10):4054-4067. PubMed ID: 32767183 [TBL] [Abstract][Full Text] [Related]
29. Mechanistic insights into the protective impact of zinc on sepsis. Souffriau J; Libert C Cytokine Growth Factor Rev; 2018 Feb; 39():92-101. PubMed ID: 29279185 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models. Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144 [TBL] [Abstract][Full Text] [Related]
31. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials. Pietroiusti A; Magrini A; Campagnolo L Toxicol Appl Pharmacol; 2016 May; 299():90-5. PubMed ID: 26723910 [TBL] [Abstract][Full Text] [Related]
32. Role of Microbiome and Antibiotics in Autoimmune Diseases. Vangoitsenhoven R; Cresci GAM Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703 [TBL] [Abstract][Full Text] [Related]
33. Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective. Vemuri R; Gundamaraju R; Shastri MD; Shukla SD; Kalpurath K; Ball M; Tristram S; Shankar EM; Ahuja K; Eri R Biomed Res Int; 2018; 2018():4178607. PubMed ID: 29682542 [TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer. Di Modica M; Gargari G; Regondi V; Bonizzi A; Arioli S; Belmonte B; De Cecco L; Fasano E; Bianchi F; Bertolotti A; Tripodo C; Villani L; Corsi F; Guglielmetti S; Balsari A; Triulzi T; Tagliabue E Cancer Res; 2021 Apr; 81(8):2195-2206. PubMed ID: 33483370 [TBL] [Abstract][Full Text] [Related]
35. The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance. Ranallo RT; McDonald LC; Halpin AL; Hiltke T; Young VB J Infect Dis; 2021 Jun; 223(12 Suppl 2):S187-S193. PubMed ID: 33667294 [TBL] [Abstract][Full Text] [Related]
36. Sepsis National Hospital Inpatient Quality Measure (SEP-1): Multistakeholder Work Group Recommendations for Appropriate Antibiotics for the Treatment of Sepsis. Septimus EJ; Coopersmith CM; Whittle J; Hale CP; Fishman NO; Kim TJ Clin Infect Dis; 2017 Oct; 65(9):1565-1569. PubMed ID: 29048513 [TBL] [Abstract][Full Text] [Related]
37. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease. Caputi V; Giron MC Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798 [TBL] [Abstract][Full Text] [Related]
38. The Gut Microbiome Modulates Body Temperature Both in Sepsis and Health. Bongers KS; Chanderraj R; Woods RJ; McDonald RA; Adame MD; Falkowski NR; Brown CA; Baker JM; Winner KM; Fergle DJ; Hinkle KJ; Standke AK; Vendrov KC; Young VB; Stringer KA; Sjoding MW; Dickson RP Am J Respir Crit Care Med; 2023 Apr; 207(8):1030-1041. PubMed ID: 36378114 [No Abstract] [Full Text] [Related]
39. Gut microbiome dysbiosis in neonatal sepsis. Verma J; Sankar MJ; Atmakuri K; Agarwal R; Das B Prog Mol Biol Transl Sci; 2022; 192(1):125-147. PubMed ID: 36280317 [TBL] [Abstract][Full Text] [Related]